EUVIMEDEUVIMED entdecken
Crossref

Nanotechnology-enabled targeted delivery of incretin therapies for the treatment of obesity and metabolic disorders

Daniel Ejim Uti, Josephine E. Egbung, Esther Ugo Alum, Inalegwu Bawa, Samuel Ali Agada, Celestine O. Ogbu, Okechukwu Paul-Chima Ugwu

Obesity Medicine · 2026-05 · 61 · 100712

DOI: 10.1016/j.obmed.2026.100712 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Obesity Medicine, 2026-05. Verfasst von Daniel Ejim Uti und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 217 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Uti, D. E., Egbung, J. E., Alum, E. U., Bawa, I., Agada, S. A., Ogbu, C. O., & Ugwu, O. P. (2026). Nanotechnology-enabled targeted delivery of incretin therapies for the treatment of obesity and metabolic disorders. Obesity Medicine, 61, 100712. https://doi.org/10.1016/j.obmed.2026.100712

Vancouver

Uti DE, Egbung JE, Alum EU, Bawa I, Agada SA, Ogbu CO, et al. Nanotechnology-enabled targeted delivery of incretin therapies for the treatment of obesity and metabolic disorders. Obesity Medicine. 2026;61:100712. doi:10.1016/j.obmed.2026.100712

BibTeX
@article{Uti2026,
  author = {Uti, Daniel Ejim and Egbung, Josephine E. and Alum, Esther Ugo and Bawa, Inalegwu and Agada, Samuel Ali and Ogbu, Celestine O. and Ugwu, Okechukwu Paul-Chima},
  title = {Nanotechnology-enabled targeted delivery of incretin therapies for the treatment of obesity and metabolic disorders},
  journal = {Obesity Medicine},
  year = {2026},
  volume = {61},
  pages = {100712},
  doi = {10.1016/j.obmed.2026.100712}
}
Kostenlos starten →